• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Association of HLA-A*11:01 with Sulfonamide-Related Severe Cutaneous Adverse Reactions in Japanese Patients.

作者信息

Nakamura Ryosuke, Ozeki Takeshi, Hirayama Noriaki, Sekine Akihiro, Yamashita Taiki, Mashimo Yoichi, Mizukawa Yoshiko, Shiohara Tetsuo, Watanabe Hideaki, Sueki Hirohiko, Ogawa Kohei, Asada Hideo, Kaniwa Nahoko, Tsukagoshi Eri, Matsunaga Kayoko, Niihara Hiroyuki, Yamaguchi Yukie, Aihara Michiko, Mushiroda Taisei, Saito Yoshiro, Morita Eishin

机构信息

Division of Medicinal Safety Science, National Institute of Health Sciences, Kawasaki, Japan.

Laboratory for Pharmacogenomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.

出版信息

J Invest Dermatol. 2020 Aug;140(8):1659-1662.e6. doi: 10.1016/j.jid.2019.12.025. Epub 2020 Jan 23.

DOI:10.1016/j.jid.2019.12.025
PMID:31981579
Abstract
摘要

相似文献

1
Association of HLA-A*11:01 with Sulfonamide-Related Severe Cutaneous Adverse Reactions in Japanese Patients.日本患者中HLA - A*11:01与磺胺类药物相关严重皮肤不良反应的关联
J Invest Dermatol. 2020 Aug;140(8):1659-1662.e6. doi: 10.1016/j.jid.2019.12.025. Epub 2020 Jan 23.
2
A novel multiplex polymerase chain reaction assay for detection of both HLA-A*31:01/HLA-B*15:02 alleles, which confer susceptibility to carbamazepine-induced severe cutaneous adverse reactions.一种用于检测 HLA-A*31:01/HLA-B*15:02 等位基因的新型多重聚合酶链反应检测方法，该等位基因与卡马西平诱导的严重皮肤不良反应易感性相关。
HLA. 2017 Dec;90(6):335-342. doi: 10.1111/tan.13143. Epub 2017 Oct 2.
3
[Stevens-Johnson syndrome in a patient with positive lymphocyte transformation test].[淋巴细胞转化试验阳性患者的史蒂文斯-约翰逊综合征]
Rev Alerg Mex. 2023 May 24;70(1):38-42. doi: 10.29262/ram.v70i1.1047.
4
Sulfonamide Hypersensitivity: Fact and Fiction.磺胺类药物过敏：事实与虚构。
J Allergy Clin Immunol Pract. 2019 Sep-Oct;7(7):2116-2123. doi: 10.1016/j.jaip.2019.05.034.
5
Association of HLA-A*31:01 Screening With the Incidence of Carbamazepine-Induced Cutaneous Adverse Reactions in a Japanese Population.HLA-A*31:01 筛查与日本人群中卡马西平诱导的皮肤不良反应发生率的关联。
JAMA Neurol. 2018 Jul 1;75(7):842-849. doi: 10.1001/jamaneurol.2018.0278.
6
Association of HLA-B*15:13 and HLA-B*15:02 with phenytoin-induced severe cutaneous adverse reactions in a Malay population.HLA - B*15:13和HLA - B*15:02与马来人群中苯妥英钠诱导的严重皮肤不良反应的关联
Pharmacogenomics J. 2017 Mar;17(2):170-173. doi: 10.1038/tpj.2016.10. Epub 2016 Mar 1.
7
HLA-B*5801: utility and cost-effectiveness in the Asia-Pacific Region.HLA-B*5801：在亚太地区的实用性和成本效益。
Int J Rheum Dis. 2013 Jun;16(3):254-7. doi: 10.1111/1756-185X.12050. Epub 2013 Apr 26.
8
Association between HLA-B Alleles and Carbamazepine-Induced Maculopapular Exanthema and Severe Cutaneous Reactions in Thai Patients.泰国患者 HLA-B 等位基因与卡马西平诱导的斑丘疹和严重皮肤反应的关联。
J Immunol Res. 2018 Jan 10;2018:2780272. doi: 10.1155/2018/2780272. eCollection 2018.
9
Sulfonamide Hypersensitivity.磺胺类药物过敏。
Clin Rev Allergy Immunol. 2022 Jun;62(3):400-412. doi: 10.1007/s12016-021-08872-3. Epub 2021 Jul 1.
10
Genetic variants associated with phenytoin-related severe cutaneous adverse reactions.与苯妥英相关的严重皮肤不良反应相关的遗传变异。
JAMA. 2014 Aug 6;312(5):525-34. doi: 10.1001/jama.2014.7859.

引用本文的文献

1
HLA-B Alleles with Shared Peptide Binding Specificities Define Global Risk of Cotrimoxazole-induced SCAR.具有共享肽结合特异性的HLA - B等位基因决定了复方新诺明诱导的严重皮肤不良反应的全球风险。
medRxiv. 2025 May 28:2025.05.28.25328237. doi: 10.1101/2025.05.28.25328237.
2
*05:01 and *11:01 Is Associated with Adverse Drug Reactions to Isoniazid and Rifampin for Treatment of Latent Tuberculosis Infection in South Korea.05:01和11:01与韩国潜伏性结核感染治疗中异烟肼和利福平的药物不良反应相关。
J Clin Med. 2024 Jun 18;13(12):3563. doi: 10.3390/jcm13123563.
3
Genotypic and Phenotypic Characteristics of Co-Trimoxazole-Induced Cutaneous Adverse Reactions.
复方新诺明诱导的皮肤不良反应的表型和基因型特征。
Dermatology. 2023;239(6):966-975. doi: 10.1159/000534342. Epub 2023 Oct 4.
4
Advances in understanding of the pathogenesis and therapeutic implications of drug reaction with eosinophilia and systemic symptoms: an updated review.药物超敏反应伴嗜酸性粒细胞增多和全身症状的发病机制及治疗意义的研究进展：最新综述
Front Med (Lausanne). 2023 Jun 29;10:1187937. doi: 10.3389/fmed.2023.1187937. eCollection 2023.
5
Clinical Manifestations and Genetic Influences in Sulfonamide-Induced Hypersensitivity.磺胺类药物所致超敏反应的临床表现及遗传影响
Drug Healthc Patient Saf. 2022 Jul 21;14:113-124. doi: 10.2147/DHPS.S347522. eCollection 2022.
6
An Updated Review of Genetic Associations With Severe Adverse Drug Reactions: Translation and Implementation of Pharmacogenomic Testing in Clinical Practice.严重药物不良反应的遗传关联最新综述：临床实践中药基因组检测的转化与应用
Front Pharmacol. 2022 Apr 25;13:886377. doi: 10.3389/fphar.2022.886377. eCollection 2022.
7
Genomic Risk Factors Driving Immune-Mediated Delayed Drug Hypersensitivity Reactions.驱动免疫介导的迟发性药物超敏反应的基因组风险因素。
Front Genet. 2021 Apr 16;12:641905. doi: 10.3389/fgene.2021.641905. eCollection 2021.
8
Implementation of Pharmacogenomic Information on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症的药物基因组学信息的应用
Front Med (Lausanne). 2021 Mar 24;8:644154. doi: 10.3389/fmed.2021.644154. eCollection 2021.